CN101678069A - 利用免疫调节剂化合物治疗过敏性疾病 - Google Patents

利用免疫调节剂化合物治疗过敏性疾病 Download PDF

Info

Publication number
CN101678069A
CN101678069A CN200880016455A CN200880016455A CN101678069A CN 101678069 A CN101678069 A CN 101678069A CN 200880016455 A CN200880016455 A CN 200880016455A CN 200880016455 A CN200880016455 A CN 200880016455A CN 101678069 A CN101678069 A CN 101678069A
Authority
CN
China
Prior art keywords
scv
ova
treatment
animals
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200880016455A
Other languages
English (en)
Chinese (zh)
Inventor
亚历山大·A·科洛博夫
安德雷·S·辛比尔采夫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sciclone Pharmaceuticals LLC
Original Assignee
Sciclone Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sciclone Pharmaceuticals LLC filed Critical Sciclone Pharmaceuticals LLC
Publication of CN101678069A publication Critical patent/CN101678069A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN200880016455A 2007-05-17 2008-05-13 利用免疫调节剂化合物治疗过敏性疾病 Pending CN101678069A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
RU2007118237/14A RU2007118237A (ru) 2007-05-17 2007-05-17 Способ лечения аллергических заболеваний
RU2007118237 2007-05-17
US95720107P 2007-08-22 2007-08-22
US60/957,201 2007-08-22
PCT/US2008/006072 WO2008143824A1 (en) 2007-05-17 2008-05-13 Treatment of allergic disease with immunomodulator compounds

Publications (1)

Publication Number Publication Date
CN101678069A true CN101678069A (zh) 2010-03-24

Family

ID=40122024

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200880016455A Pending CN101678069A (zh) 2007-05-17 2008-05-13 利用免疫调节剂化合物治疗过敏性疾病

Country Status (14)

Country Link
US (1) US20100204295A1 (https=)
EP (1) EP2164507B1 (https=)
JP (1) JP2010527354A (https=)
KR (1) KR20100022044A (https=)
CN (1) CN101678069A (https=)
AU (1) AU2008253667A1 (https=)
BR (1) BRPI0811572A2 (https=)
CA (1) CA2684046A1 (https=)
IL (1) IL202114A0 (https=)
MX (1) MX2009012297A (https=)
NZ (1) NZ581748A (https=)
RU (1) RU2007118237A (https=)
UA (1) UA100018C2 (https=)
WO (1) WO2008143824A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090119897A (ko) * 2007-02-13 2009-11-20 사이클론 파아머슈티컬 인코오퍼레이티드 점막의 질환으로 인한 조직 악화, 상처 또는 손상을 치료 또는 예방하는 방법
RU2635968C1 (ru) * 2016-11-17 2017-11-17 Аллан Герович Бениашвили Способ лечения и профилактики состояний аллергического спектра
KR102633086B1 (ko) * 2018-11-12 2024-02-05 씨제이제일제당 주식회사 N-아세틸-l-트립토판을 유효성분으로 포함하는 젖소용 사료첨가제
WO2020242133A1 (ko) * 2019-05-24 2020-12-03 전북대학교 산학협력단 N-아실-아미노산을 유효성분으로 포함하는 천식, 비염 또는 결막염의 예방 또는 치료용 조성물
KR102376756B1 (ko) * 2019-05-24 2022-03-21 주식회사 스템디알 N-아실-아미노산을 유효성분으로 포함하는 천식, 비염 또는 결막염의 예방 또는 치료용 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728680A (en) * 1987-12-30 1998-03-17 Cytoven J.V. Methods for normalizing numbers of lymphocytes
SU1544438A1 (ru) 1988-04-04 1990-02-23 Научно-исследовательский институт онкологии им.проф.Н.Н.Петрова Способ плазмосорбции
US5032593A (en) * 1988-07-01 1991-07-16 Marion Merrell Dow Inc. Method of treating bronchoconstriction with 1,3-unsymmetrical straight chain alkyl-substituted 8-phenylxanthines
US5811399A (en) * 1988-12-14 1998-09-22 Cytran, Inc. Pharmaceutical dipeptide compositions and methods of use thereof: immunodepressants
US5916878A (en) * 1995-11-28 1999-06-29 Edward T. Wei γ-glutamyl and β-aspartyl containing immunomodulator compounds and methods therewith
US5744452A (en) * 1995-11-28 1998-04-28 Edward T. Wei γ-L-glutamyl containing immunomodulator compounds and methods therewith
US7173013B2 (en) * 2001-06-08 2007-02-06 Sciclone Pharmaceuticals, Inc. Treatment of tuberculosis using immunomodulator compounds
UA92586C2 (ru) * 2004-05-14 2010-11-25 Сайклон Фармасютикалс, Инк. Лечение или предотвращение респираторных вирусных инфекций с помощью иммуномодуляторов

Also Published As

Publication number Publication date
UA100018C2 (ru) 2012-11-12
KR20100022044A (ko) 2010-02-26
IL202114A0 (en) 2010-06-16
CA2684046A1 (en) 2008-11-27
EP2164507B1 (en) 2012-07-11
NZ581748A (en) 2012-03-30
EP2164507A4 (en) 2011-01-05
BRPI0811572A2 (pt) 2015-07-21
RU2007118237A (ru) 2008-11-27
AU2008253667A1 (en) 2008-11-27
WO2008143824A1 (en) 2008-11-27
MX2009012297A (es) 2010-02-17
EP2164507A1 (en) 2010-03-24
JP2010527354A (ja) 2010-08-12
US20100204295A1 (en) 2010-08-12

Similar Documents

Publication Publication Date Title
Maywald et al. Zinc homeostasis and immunosenescence
JP2548056B2 (ja) Ｉ型糖尿病に係る自己免疫疾患の抑制および予防用製剤
JP3902406B2 (ja) 老化防御効果を示すテトラペプチド、これを基にした薬理学的物質、及びその利用法
AU2014244744B2 (en) Pharmaceutical composition for inhibiting immune response through inducing differentiation into regulator T cells and promoting proliferation of regulator T cells
US8975294B2 (en) Desferrioxamine-metal complexes for the treatment of immune-related disorders
JP7557185B2 (ja) 免疫応答を調節するｇａｂａの能力の強化
JP2002509074A (ja) 熱ショックタンパク質を使用する、炎症性疾患を処置する方法
KR101469167B1 (ko) 봉독-ｐｌａ2를 포함하는 이상 조절 ｔ 세포 활성 저하 관련 질환의 치료 또는 예방용 약학적 조성물
US20230173031A1 (en) Thymosin alpha 1 for use in treatment of cystic fibrosis
CN101678069A (zh) 利用免疫调节剂化合物治疗过敏性疾病
US20160303150A1 (en) Deuterated trehalose formulations and uses thereof
US10213482B2 (en) Methods of treating chronic inflammatory diseases
CN115006532A (zh) 蛋白酶体抑制剂的应用
US11096987B2 (en) Mutant peptides and methods of treating subjects using the same
CN111821299A (zh) 噻吩衍生物用于治疗免疫球蛋白E（IgE）介导的疾病的应用
HK1142534A (en) Treatment of allergic disease with immunomodulator compounds
US20190352341A1 (en) Modified peptides and their use for treating systemic lupus erythematosus
TW202402321A (zh) 一種第i型甲醯胜肽受體拮抗劑及其用途
KR20120064981A (ko) 다발성신경경화증의 치료 또는 예방용 조성물 및 이의 스크리닝 방법
HK40047454A (en) Thymosin alpha 1 for use in treatment of cystic fibrosis
CN111821297A (zh) 异吲哚啉衍生物用于治疗免疫球蛋白E（IgE）介导的疾病的应用
HK1239537A1 (en) Desferrioxamine-metal complexes for the treatment of immune-related disorders
JPWO2000003703A1 (ja) 新規なアレルギー疾患治療剤

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1142534

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20100324

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1142534

Country of ref document: HK